SRPK1 and cancer: Although the aberrant expression of SRPK1 has been recorded in many cancers, including lung, prostate, male germ cells, retinoblastoma, pancreas, colon and breast, the kinase is controversially related to both chemotherapy sensitivity and resistance15–21.